2016•Cancer Chemotherapy and PharmacologyRequires access

Efficacy and safety of everolimus and sunitinib in patients with gastroenteropancreatic neuroendocrine tumor

Changhoon Yoo, Hyungwoo Cho, Min Jeong Song, Seung‐Mo Hong, Kyu‐pyo Kim, Heung-Moon Chang, Heejung Chae, Tae Won Kim, Yong Sang Hong, Min‐Hee Ryu, Yoon‐Koo Kang, Song Cheol Kim, Baek‐Yeol Ryoo

Open publisher page 32 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 32 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Everolimus, Sunitinib, Medicine, Neuroendocrine tumors, Oncology, Internal medicine, Pharmacology, Cancer

Back to paper search Browse research topics Original source

Efficacy and safety of everolimus and sunitinib in patients with gastroenteropancreatic neuroendocrine tumor — Research Paper | ScholarLens